Clinical Trial Update: Perioperative Cadonilimab Combined With Neoadjuvant Chemotherapy in Resectable Esophageal Squamous Cell Carcinoma (ESCC) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating perioperative cadonilimab in combination with neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Cadonilimab

Snippet

Sponsor: Akeso | Conditions: Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING